Literature DB >> 22796872

Broad-based nutritional supplementation in 3xTg mice corrects mitochondrial function and indicates sex-specificity in response to Alzheimer's disease intervention.

Andrew B Wolf1, B Blair Braden, Heather Bimonte-Nelson, Yael Kusne, Nicole Young, Elizabeth Engler-Chiurazzi, Alexandra N Garcia, Douglas G Walker, Guna S D Moses, Hung Tran, Frank LaFerla, LihFen Lue, Nancy Emerson Lombardo, Jon Valla.   

Abstract

Nutrition has been highlighted as a potential factor in Alzheimer's disease (AD) risk and decline and has been investigated as a therapeutic target. Broad-based combination diet therapies have the potential to simultaneously effect numerous protective and corrective processes, both directly (e.g., neuroprotection) and indirectly (e.g., improved vascular health). Here we administered either normal mouse chow with a broad-based nutritional supplement or mouse chow alone to aged male and female 3xTg mice and wildtype (WT) controls. After approximately 4 months of feeding, mice were given a battery of cognitive tasks and then injected with a radiolabeled glucose analog. Brains were assessed for differences in regional glucose uptake and mitochondrial cytochrome oxidase activity, AD pathology, and inflammatory markers. Supplementation induced behavioral changes in the 3xTg, but not WT, mice, and the mode of these changes was influenced by sex. Subsequent analyses indicated that differential response to supplementation by male and female 3xTg mice highlighted brain regional strategies for the preservation of function. Several regions involved have been shown to mediate responses to steroid hormones, indicating a mechanism for sex-based vulnerability. Thus, these findings may have broad implications for the human response to future therapeutics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22796872      PMCID: PMC3774548          DOI: 10.3233/JAD-2012-120478

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  43 in total

1.  Dietary supplementation with S-adenosyl methionine delayed amyloid-β and tau pathology in 3xTg-AD mice.

Authors:  Sangmook Lee; Cynthia A Lemere; Jeffrey L Frost; Thomas B Shea
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Progesterone reverses the spatial memory enhancements initiated by tonic and cyclic oestrogen therapy in middle-aged ovariectomized female rats.

Authors:  Heather A Bimonte-Nelson; Kevin R Francis; Claudia D Umphlet; Ann-Charlotte Granholm
Journal:  Eur J Neurosci       Date:  2006-07       Impact factor: 3.386

3.  Global prevalence of dementia: a Delphi consensus study.

Authors:  Cleusa P Ferri; Martin Prince; Carol Brayne; Henry Brodaty; Laura Fratiglioni; Mary Ganguli; Kathleen Hall; Kazuo Hasegawa; Hugh Hendrie; Yueqin Huang; Anthony Jorm; Colin Mathers; Paulo R Menezes; Elizabeth Rimmer; Marcia Scazufca
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

Review 4.  Can nutrients prevent or delay onset of Alzheimer's disease?

Authors:  Patrick J G H Kamphuis; Philip Scheltens
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

5.  Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice.

Authors:  Kavon Rezai-Zadeh; Doug Shytle; Nan Sun; Takashi Mori; Huayan Hou; Deborah Jeanniton; Jared Ehrhart; Kirk Townsend; Jin Zeng; David Morgan; John Hardy; Terrence Town; Jun Tan
Journal:  J Neurosci       Date:  2005-09-21       Impact factor: 6.167

6.  Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.

Authors:  Yvonne Freund-Levi; Maria Eriksdotter-Jönhagen; Tommy Cederholm; Hans Basun; Gerd Faxén-Irving; Anita Garlind; Inger Vedin; Bengt Vessby; Lars-Olof Wahlund; Jan Palmblad
Journal:  Arch Neurol       Date:  2006-10

7.  Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms.

Authors:  Marcus O W Grimm; Johanna Kuchenbecker; Sven Grösgen; Verena K Burg; Benjamin Hundsdörfer; Tatjana L Rothhaar; Petra Friess; Martijn C de Wilde; Laus M Broersen; Botond Penke; Mária Péter; László Vígh; Heike S Grimm; Tobias Hartmann
Journal:  J Biol Chem       Date:  2011-02-15       Impact factor: 5.157

8.  Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice.

Authors:  Lauren M Billings; Salvatore Oddo; Kim N Green; James L McGaugh; Frank M LaFerla
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

9.  Memory performance correlates with gray matter density in the ento-/perirhinal cortex and posterior hippocampus in patients with mild cognitive impairment and healthy controls--a voxel based morphometry study.

Authors:  Tobias Schmidt-Wilcke; Stefan Poljansky; Stefanie Hierlmeier; Joachim Hausner; Bernd Ibach
Journal:  Neuroimage       Date:  2009-05-13       Impact factor: 6.556

10.  Zyflamend in men with high-grade prostatic intraepithelial neoplasia: results of a phase I clinical trial.

Authors:  Jillian L Capodice; Prakash Gorroochurn; A Sam Cammack; Goluboff Eric; James M McKiernan; Mitchell C Benson; Brian A Stone; Aaron E Katz
Journal:  J Soc Integr Oncol       Date:  2009
View more
  6 in total

1.  Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice.

Authors:  Marissa J Schafer; Melissa J Alldred; Sang Han Lee; Michael E Calhoun; Eva Petkova; Paul M Mathews; Stephen D Ginsberg
Journal:  Neurobiol Aging       Date:  2014-12-04       Impact factor: 4.673

Review 2.  Obesity and sex interact in the regulation of Alzheimer's disease.

Authors:  V Alexandra Moser; Christian J Pike
Journal:  Neurosci Biobehav Rev       Date:  2015-12-18       Impact factor: 8.989

3.  Vitamin D Improves Neurogenesis and Cognition in a Mouse Model of Alzheimer's Disease.

Authors:  Maria Morello; Véréna Landel; Emmanuelle Lacassagne; Kevin Baranger; Cedric Annweiler; François Féron; Pascal Millet
Journal:  Mol Neurobiol       Date:  2018-01-09       Impact factor: 5.590

4.  Probiotics for Alzheimer's Disease: A Systematic Review.

Authors:  Ruth Naomi; Hashim Embong; Fezah Othman; Hasanain Faisal Ghazi; Nithiyah Maruthey; Hasnah Bahari
Journal:  Nutrients       Date:  2021-12-22       Impact factor: 5.717

5.  Prophylactic melatonin significantly reduces Alzheimer's neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPP(swe)/PS1 mice.

Authors:  G O'Neal-Moffitt; V Delic; P C Bradshaw; J Olcese
Journal:  Mol Neurodegener       Date:  2015-07-11       Impact factor: 14.195

6.  Altered Energy Metabolism Pathways in the Posterior Cingulate in Young Adult Apolipoprotein E ɛ4 Carriers.

Authors:  Michelle Perkins; Andrew B Wolf; Bernardo Chavira; Daniel Shonebarger; J P Meckel; Lana Leung; Lauren Ballina; Sarah Ly; Aman Saini; T Bucky Jones; Johana Vallejo; Garilyn Jentarra; Jon Valla
Journal:  J Alzheimers Dis       Date:  2016-04-23       Impact factor: 4.472

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.